Efficacy Study of Kinto Care Coaching for Dementia Family Caregivers

Alzheimer Disease Clinical Trial

Official title: Phase II Efficacy Study of a Technology-enabled Care Coaching Service for Families Caring for AD/ADRD

Status Completed

Clinical Trial Summary

The goal of this clinical trial is to evaluate Kinto's Care Coaching intervention for dementia caregivers.

The main questions it aims to answer are:

Does the intervention help caregivers to address their general caregiving goals Does the intervention help caregivers to address their financial caregiving goals

Participants will have access to:

One-on-one care coaching sessions (via zoom) Up to 6 weekly support groups with other caregivers A variety of digital resources through Kinto's mobile app

Researchers will compare intervention and control groups to see if the program supports caregivers' general and financial caregiving needs.

The efficacy of the intervention also will be examined on key outcomes.

Clinical Trial Description

The study will include 300 family caregivers drawn from throughout the US, who will engage remotely with the coaches (and one another) using zoom and Kinto's mobile caregiver app.

Caregivers will be randomly assigned to one of two groups to evaluate the impact of the program by making a comparison of those caregivers who received the program (Group

1) and those caregivers who will not receive the program (Group 2). Caregivers assigned to Group 2, the control condition, will be eligible to receive a modified version of the program after completion of the study and data collection protocols.

The intervention is a care coaching program that assists caregivers with their general caregiving goals and financial caregiving goals. Caregivers will attend a one-on-one care coaching session conducted via Zoom for 60-75 minutes with a care coach and will engage with their care coach through chat-based interactions after completing the session. If requested, up to two additional care coaching sessions will be scheduled.

Caregivers also will have the opportunity to attend up to 6 weekly support groups with other caregivers facilitated by a care coach and receive a variety of digital resources through the mobile app.

As guided by the NIH Stage Model for Behavioral Intervention Development, the primary goal of the Phase 2 study is to examine the efficacy of the program on select outcomes for caregivers (i.e., Stage III Real-World Efficacy). As such, the selected data collection periods of T1 (prior to the intervention), T2 (immediately following the initial six week intervention period) and T3 (45 days following this date) will evaluate the immediate and short-term efficacy of the program.

Recruiting of caregivers is scheduled to begin in May 2023. The study plan targets recruitment of three cohorts, each with one hundred participants. The first intervention group will begin the program in August 2023. Subsequent cohorts will begin the study at 8-9 week intervals. The plan includes a contingency to run two additional cohorts (to mitigate any recruitment or retention risk). In the event that all five cohorts are used to achieve participation goals, the final cohort is scheduled to complete the intervention and survey requirements no later than August of 2024. ;

Related Conditions & MeSH terms

• Alzheimer Disease
• Aphasia, Primary Progressive
• Dementia
• Dementia, Vascular
• Frontotemporal Dementia
• Lewy Body Disease
• Mixed Dementia
• Pick Disease of the Brain
• Vascular Dementia

• NCT number: NCT05916664
• Study type: Interventional
• Source: Kinto
• Status: Completed
• Phase: N/A
• Start date: May 18, 2023
• Completion date: April 22, 2024